Next 10 |
SPAC Khosla Ventures Acquisition (NASDAQ:KVSA) and Valo Health agreed to terminate a $2.8B business combination. KVSA gained 1.3%. The SPAC and its target cited current market conditions, particularly in the biotechnology area, according to a statement yesterday. SPAC Khosla Ventur...
Valo Health and Khosla Ventures Acquisition Co. Mutually Agree to Terminate Business Combination Agreement PR Newswire BOSTON and MENLO PARK, Calif. , Nov. 15, 2021 /PRNewswire/ -- Valo Health, LLC ("Valo"), the technology company using human-centric dat...
Valo Health and Khosla Ventures Acquisition Co. Announce Additional PIPE Commitments - Additional PIPE commitments since SPAC announcement total $33.5M - Anticipated PIPE proceeds total over $200M exceeding initial targets - New commitments made by CEO & Founder, Dav...
Khosla Ventures Acquisition (NASDAQ:KVSA) announced that it will voluntarily transfer the listing of its Class A common stock from Nasdaq to NYSE post the closure of its earlier announced business combination with Valo Health. The shares of the post-business combination to be rename...
Khosla Ventures Acquisition Co. Announces Planned Transfer of Listing to NYSE in Connection with its Proposed Business Combination with Valo Health PR Newswire BOSTON and MENLO PARK, Calif. , Oct. 28, 2021 /PRNewswire/ -- Khosla Ventures Acquisition Co. ...
Khosla Ventures Acquisition Co. announces Special Meeting of Stockholders to approve business combination with Valo Health Special Meeting of Stockholders to be held on November 16, 2021 at 10:00 a.m. ET PR Newswire BOSTON and MENLO PARK, Calif. , Oct. 25, ...
ljubaphoto/E+ via Getty Images Boston Biotherapeutics company Gelesis is set to become a public company following a merger with Capstar Special Purpose Acquisition Corp ([[CPSRU]] -0.6%). The deal is expected to generate $376M for the combined company and values Gelesis at a market value of $...
Bim/E+ via Getty Images Sarah Friar, CEO of NextDoor (KIND), said Tuesday the company will use proceeds from its SPAC IPO to "keep growing the neighborhood" by adding areas to its hyperlocal social-media network. In an interview with CNBC, Friar detailed that funds will also go towards growin...
Shares of Khosla Ventures Acquisition Co. (NASDAQ:KVSA) traded at a new 52-week low today of $9.88. Approximately 124,000 shares have changed hands today, as compared to an average 30-day volume of 350,000 shares. Over the past year, Khosla Ventures Acquisition Co. has traded in a range ...
Khosla Ventures Acquisition Co. (NASDAQ:KVSA) traded at a new 52-week low today of $9.87. This new low was reached on below average trading volume as 124,000 shares traded hands, while the average 30-day volume is approximately 350,000 shares. Over the past year, Khosla Ventures Acquisit...
News, Short Squeeze, Breakout and More Instantly...
Khosla Ventures Acquisition Co. Company Name:
KVSA Stock Symbol:
NASDAQ Market:
Khosla Ventures Acquisition Co. Website:
Valo Health and Khosla Ventures Acquisition Co. Mutually Agree to Terminate Business Combination Agreement PR Newswire BOSTON and MENLO PARK, Calif. , Nov. 15, 2021 /PRNewswire/ -- Valo Health, LLC ("Valo"), the technology company using human-centric dat...
Valo Health and Khosla Ventures Acquisition Co. Announce Additional PIPE Commitments - Additional PIPE commitments since SPAC announcement total $33.5M - Anticipated PIPE proceeds total over $200M exceeding initial targets - New commitments made by CEO & Founder, Dav...
Khosla Ventures Acquisition Co. Announces Planned Transfer of Listing to NYSE in Connection with its Proposed Business Combination with Valo Health PR Newswire BOSTON and MENLO PARK, Calif. , Oct. 28, 2021 /PRNewswire/ -- Khosla Ventures Acquisition Co. ...